Vanguard Group’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$15.7M Buy
4,176,574
+44,921
+1% +$169K ﹤0.01% 2670
2025
Q1
$18.7M Sell
4,131,653
-263,078
-6% -$1.19M ﹤0.01% 2531
2024
Q4
$31.1M Sell
4,394,731
-185,832
-4% -$1.31M ﹤0.01% 2371
2024
Q3
$37.3M Buy
4,580,563
+53,583
+1% +$436K ﹤0.01% 2304
2024
Q2
$28.9M Buy
4,526,980
+50,749
+1% +$324K ﹤0.01% 2380
2024
Q1
$33.7M Sell
4,476,231
-1,031,741
-19% -$7.77M ﹤0.01% 2341
2023
Q4
$51M Sell
5,507,972
-933,735
-14% -$8.65M ﹤0.01% 2182
2023
Q3
$65.2M Buy
6,441,707
+78,823
+1% +$798K ﹤0.01% 2009
2023
Q2
$79.5M Buy
6,362,884
+164,371
+3% +$2.05M ﹤0.01% 1972
2023
Q1
$72.3M Buy
6,198,513
+128,985
+2% +$1.51M ﹤0.01% 1992
2022
Q4
$64.5M Buy
6,069,528
+127,870
+2% +$1.36M ﹤0.01% 2040
2022
Q3
$57.6M Buy
5,941,658
+636,395
+12% +$6.17M ﹤0.01% 2114
2022
Q2
$76.9M Buy
5,305,263
+1,069,889
+25% +$15.5M ﹤0.01% 1976
2022
Q1
$111M Sell
4,235,374
-47,365
-1% -$1.24M ﹤0.01% 1884
2021
Q4
$170M Buy
4,282,739
+163,505
+4% +$6.48M ﹤0.01% 1703
2021
Q3
$206M Buy
4,119,234
+617,003
+18% +$30.9M 0.01% 1590
2021
Q2
$194M Buy
3,502,231
+530,293
+18% +$29.4M ﹤0.01% 1644
2021
Q1
$139M Buy
2,971,938
+87,306
+3% +$4.08M ﹤0.01% 1776
2020
Q4
$126M Buy
2,884,632
+267,430
+10% +$11.6M ﹤0.01% 1720
2020
Q3
$95.8M Buy
2,617,202
+554,293
+27% +$20.3M ﹤0.01% 1702
2020
Q2
$60.2M Buy
2,062,909
+1,170,020
+131% +$34.1M ﹤0.01% 1915
2020
Q1
$23.3M Buy
892,889
+99,296
+13% +$2.6M ﹤0.01% 2211
2019
Q4
$27.5M Buy
793,593
+67,917
+9% +$2.36M ﹤0.01% 2380
2019
Q3
$23M Buy
+725,676
New +$23M ﹤0.01% 2420